Global Nucleic Acid Testing-NAT Instrumentation Market – Industry Trends and Forecast to 2028

Demande de table des matières Demande de table des matières Parler à un analysteParler à un analyste Exemple de rapport gratuitExemple de rapport gratuit Renseignez-vous avant d'acheterRenseignez-vous avant Acheter maintenantAcheter maintenant

Global Nucleic Acid Testing-NAT Instrumentation Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Upcoming Reports
  • Apr 2021
  • Global
  • 350 Pages
  • Nombre de tableaux : 220
  • Nombre de figures : 60
  • Author : Sachin Pawar

Global Nucleic Acid Testing Nat Instrumentation Market

Taille du marché en milliards USD

TCAC :  % Diagram

Chart Image USD 1,378.06 Million USD 2,204.73 Million 2020 2028
Diagram Période de prévision
2021 –2028
Diagram Taille du marché (année de référence)
USD 1,378.06 Million
Diagram Taille du marché (année de prévision)
USD 2,204.73 Million
Diagram TCAC
%
Diagram Principaux acteurs du marché
  • Novartis AG
  • BD
  • Abbott
  • Danaher.
  • Thermo Fisher Scientific Inc.

Global Nucleic Acid Testing-NAT Instrumentation Market, By Technology (Polymerase Chain Reaction (PCR), Ligase Chain Reaction (LCR), Transcription–mediated Amplification (TMA), Whole Genome Sequencing and Others), Application (Disease Diagnosis, Forensic Testing, Personalized Medicine and  Others), End Users (Hospitals, Speciality Clinics, Diagnostic Centres, Academic and Research Institutes and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028

Global Nucleic Acid Testing-NAT Instrumentation MarketMarket Analysis and Insights of Nucleic Acid Testing-NAT Instrumentation Market

Data Bridge Market Research analyses that the nucleic acid Testing-NAT instrumentation market will exhibit a CAGR of around 6.05% for the forecast period of 2021-2028. Rise in the trend of personalized medicine, advancements in tools for synthetic genome designs and rising prevalence of infectious diseases are the major factors attributable to the growth of nucleic acid Testing-NAT instrumentation market. Therefore, the market value, currently standing on USD 1,378.06 million will rocket up to USD 2,204.73 million by the year 2028.

Nucleic acid test is a medical technology that is used to detect the presence of any virus of bacteria which act as disease-causing pathogens. The nucleic acid test is conducted with the help of NAT instrumentation using biological samples such as urine, blood, tissues and so on.

Rising demand for nucleic acid test kits from blood transfusion centres and blood banks is one of the major factors fostering the growth of nucleic acid Testing-NAT instrumentation market. Rising expenditure for technological advancements and research and development by the healthcare industries is another important factor bolstering the growth of nucleic acid Testing-NAT instrumentation market. Rising prevalence of genetic diseases and other infectious diseases such as malaria, dengue and so on will further create lucrative market growth opportunities.

However, dearth of skilled or trained healthcare professionals will derail the market growth rate. Unfavourable reimbursement policies especially in the developing economies will further pose challenges for the market growth. Lack of sophisticated healthcare infrastructure in the underdeveloped economies coupled with high sensitivity factors are some other market growth restraints.

This nucleic acid Testing-NAT instrumentation market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on nucleic acid Testing-NAT instrumentation market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Nucleic Acid Testing-NAT Instrumentation Market Scope and Market Size

The nucleic acid Testing-NAT instrumentation market is segmented on the basis of technology, application and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of technology, the nucleic acid Testing-NAT instrumentation market is classified into polymerase chain reaction (PCR), ligase chain reaction (LCR), transcription–mediated amplification (TMA), whole genome sequencing and others.
  • On the basis of application, the nucleic acid Testing-NAT instrumentation market is segmented into disease diagnosis, forensic testing, personalized medicine and others.
  • On the basis of end users, the nucleic acid Testing-NAT instrumentation market is bifurcated into hospitals, speciality clinics, diagnostic centres, academic and research institutes and others.

Nucleic Acid Testing-NAT Instrumentation Market Country Level Analysis

The nucleic acid Testing-NAT instrumentation market is analysed and market size insights and trends are provided by country, technology, application and end users as referenced above.

The countries covered in the nucleic acid Testing-NAT instrumentation market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the nucleic acid Testing-NAT instrumentation market and will continue to flourish its trend of dominance during the forecast period. This is because of the increasing expenditure for research and developmental proficiencies by the major key players. Rising prevalence of infectious diseases is another factor fostering the market growth in this region. Asia-Pacific on the other hand is projected to score the highest CAGR for the forecast period owing to the increased public and private expenditure for the development of healthcare infrastructure and increased awareness regarding nucleic acid testing.  

The country section of the nucleic acid Testing-NAT instrumentation market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Nucleic acid Testing-NAT instrumentation market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital health technologies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the nucleic acid Testing-NAT instrumentation market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Nucleic Acid Testing-NAT Instrumentation Market Share Analysis

The nucleic acid Testing-NAT instrumentation market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to nucleic acid Testing-NAT instrumentation market.

The major players covered in the nucleic acid Testing-NAT instrumentation market report are Novartis AG, BD, Abbott, Danaher., Thermo Fisher Scientific Inc., bioMérieux SA, Biomerica, Inc., F. Hoffmann-La Roche Ltd, Siemens AG, Johnson & Johnson Services, Inc., Beckman Coulter, Inc., Hologic, Inc., Bio-Rad Laboratories, Inc., Bayer AG, Illumina, Inc., Grifols, S.A., Quest Diagnostics Incorporated. and Tecan Trading AG,among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-

Accédez en ligne au rapport sur le premier cloud mondial de veille économique

  • Tableau de bord d'analyse de données interactif
  • Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
  • Accès d'analyste de recherche pour la personnalisation et les requêtes
  • Analyse de la concurrence avec tableau de bord interactif
  • Dernières actualités, mises à jour et analyse des tendances
  • Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Demande de démonstration

Méthodologie de recherche

La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.

La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.

Personnalisation disponible

Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.

Questions fréquemment posées

Le marché est segmenté en fonction de Global Nucleic Acid Testing-NAT Instrumentation Market, By Technology (Polymerase Chain Reaction (PCR), Ligase Chain Reaction (LCR), Transcription–mediated Amplification (TMA), Whole Genome Sequencing and Others), Application (Disease Diagnosis, Forensic Testing, Personalized Medicine and  Others), End Users (Hospitals, Speciality Clinics, Diagnostic Centres, Academic and Research Institutes and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028 .
La taille du Global Nucleic Acid Testing-NAT Instrumentation Market était estimée à 1378.06 USD Million USD en 2020.
Le Global Nucleic Acid Testing-NAT Instrumentation Market devrait croître à un TCAC de 6.05% sur la période de prévision de 2021 à 2028.
Les principaux acteurs du marché sont Novartis AG, BD, Abbott, Danaher., Thermo Fisher Scientific Inc., bioMérieux SA, BiomericaInc., F. Hoffmann-La Roche Ltd, Siemens AG, Johnson & Johnson ServicesInc., Beckman CoulterInc., HologicInc., Bio-Rad LaboratoriesInc., Bayer AG, IlluminaInc., GrifolsS.A., Quest Diagnostics Incorporated. and Tecan Trading AG,.
Testimonial